The HPTN089 study tests the tolerability, safety, and the immune system’s response to combinations of experimental HIV antibodies.
- We are looking for 18–50 year olds
- HIV uninfected individuals
- Participation in this study will range from 12–16 months
- Participants will be compensated $1,000 for their time
For more information, call 617-927-6450 or email email@example.com
To find out if you are eligible, click here.